Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25491978 |
US |
||
Erythema, Condition aggravated, Rash, Product use in unapproved indication, |
||||
CALCIPOTRIENE, |
||||
2 | 25492089 |
PL |
28 | 2 |
Skin burning sensation, Pain, Headache, Ear pain, Ear discomfort, Lip pain, Anorgasmia, Blood pressure increased, Erythema, |
||||
DIMETHYL FUMARATE, |
||||
3 | 25492112 |
GB |
52 | 1 |
Erythema, Cough, Head discomfort, |
||||
INFLIXIMAB, |
||||
4 | 25492191 |
US |
55 | 1 |
Skin burning sensation, Erythema, Blister, Pruritus, |
||||
INSULIN LISPRO, SEMAGLUTIDE, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
5 | 25492751 |
PL |
85 | 1 |
Death, Skin bacterial infection, General physical health deterioration, C-reactive protein increased, Skin burning sensation, Diffuse large B-cell lymphoma, Erythema, Pruritus, Thrombocytopenia, Blood lactate dehydrogenase increased, |
||||
6 | 25493087 |
US |
2 | |
Pruritus, Erythema, |
||||
SPARSENTAN, |
||||
7 | 25493231 |
US |
2 | |
Erythema, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
NIRAPARIB, NIRAPARIB, |
||||
8 | 25493385 |
MX |
2 | |
Hip fracture, Gait inability, Tremor, Pruritus, Bone disorder, Dysstasia, Gait disturbance, Urticaria, Fatigue, Erythema, Constipation, Arthralgia, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, |
||||
9 | 25493851 |
US |
72 | 2 |
Erythema, Pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
10 | 25494695 |
US |
7 | 1 |
Erythema, Swelling face, Dark circles under eyes, |
||||
11 | 25494975 |
AR |
2 | |
Erythema, Hyperthermia, Tremor, Tachypnoea, |
||||
GALSULFASE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
12 | 25495172 |
US |
39 | 2 |
Hypoaesthesia, Erythema, Paraesthesia, Throat irritation, Chest discomfort, |
||||
IRON SUCROSE, IRON SUCROSE, |
||||
13 | 25495674 |
US |
1 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
14 | 25495692 |
US |
2 | |
Dermatitis atopic, Pruritus, Erythema, Dermatitis, |
||||
DUPILUMAB, |
||||
15 | 25495809 |
US |
43 | 1 |
Dermatitis atopic, Erythema, Swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
16 | 25495891 |
US |
32 | 2 |
Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
17 | 25496148 |
CA |
20 | 1 |
Dizziness, Erythema, Neurogenic shock, Oedema, Pallor, Off label use, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
18 | 25496174 |
CN |
56 | 1 |
Erythema, Pruritus, Hypersensitivity, |
||||
CYTARABINE, |
||||
19 | 25496212 |
CA |
40 | 2 |
Wound infection, Pruritus, Somnolence, Abdominal distension, Neck pain, Hepatitis, Dyspepsia, Muscular weakness, Back injury, Nail disorder, Coeliac disease, Mobility decreased, Derealisation, Wheezing, Headache, Depressed mood, Peripheral coldness, Adverse reaction, Gait inability, Condition aggravated, Temperature intolerance, Diarrhoea, Decreased appetite, Urticaria, Product label confusion, Malaise, Insomnia, Respiratory tract congestion, Heart rate increased, Weight increased, Blister, Suicidal ideation, Burning sensation, Feeling abnormal, Asthenia, Weight decreased, Gastrooesophageal reflux disease, Intentional product use issue, Hypoaesthesia, Fatigue, Grip strength decreased, Alopecia, Sleep disorder, Bursitis, Musculoskeletal stiffness, Pain in extremity, Nausea, Erythema, Fall, Off label use, Folliculitis, Gastrointestinal disorder, Finger deformity, Liver function test increased, Osteoarthritis, Injury, Pneumonia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, CANDESARTAN, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PHENYLEPHRINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERGOCALCIFEROL, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, GABAPENTIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
20 | 25496230 |
US |
1 | |
Pruritus, Rash, Erythema, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
21 | 25496371 |
US |
18 | 2 |
Hypersensitivity, Erythema, Urticaria, Pruritus, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, FAMOTIDINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
22 | 25496380 |
US |
9 | 1 |
Rebound atopic dermatitis, Erythema, Product dose omission issue, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ALBUTEROL SULFATE, |
||||
23 | 25496627 |
US |
34 | 1 |
Psoriasis, Erythema, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
24 | 25491069 |
US |
58 | 1 |
Sleep disorder due to a general medical condition, Dry skin, Erythema, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
25 | 25491345 |
US |
64 | 1 |
Skin fissures, Rash erythematous, Erythema, Pruritus, Skin burning sensation, Product use in unapproved indication, Product administered at inappropriate site, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
26 | 25491364 |
US |
31 | 2 |
Erythema, Condition aggravated, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
27 | 25491587 |
CA |
53 | 2 |
Thrombosis, Pruritus, Erythema, Erythema, Skin plaque, Compression fracture, Skin exfoliation, |
||||
RISANKIZUMAB-RZAA, |
||||
28 | 25489946 |
CA |
37 | 2 |
Angioedema, Dyspnoea, Middle insomnia, Pyelonephritis, Rash, Visual impairment, Blood pressure increased, Exposure to SARS-CoV-2, Pain, Therapy partial responder, Oedema peripheral, Oropharyngeal pain, Infection, Mechanical urticaria, Peripheral swelling, Pruritus, Skin reaction, Weight decreased, Arthralgia, Bronchitis, Chronic sinusitis, Diarrhoea, Generalised oedema, Injection site extravasation, COVID-19, Pneumonia, Pyrexia, Temperature intolerance, Urticaria, Addison^s disease, Autoimmune hepatitis, Drug ineffective, Fatigue, Haematemesis, Heart rate increased, Palpitations, Tuberculosis, Chest discomfort, Erythema, Nausea, |
||||
METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, REPAGLINIDE, ETANERCEPT, KETOTIFEN FUMARATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMALIZUMAB, APREMILAST, OMALIZUMAB, OMALIZUMAB, |
||||
29 | 25489950 |
US |
2 | 2 |
Rebound eczema, Pruritus, Erythema, Skin swelling, Product storage error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
30 | 25490014 |
US |
43 | 2 |
Erythema, Dermatitis, Rash, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
31 | 25490115 |
US |
18 | 1 |
Inflammation, Erythema, Injection site pain, |
||||
DUPILUMAB, |
||||
32 | 25490122 |
US |
3 | 1 |
Eczema, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
33 | 25490240 |
US |
67 | 1 |
Dermatitis contact, Condition aggravated, Pruritus, Erythema, Inflammation, Anxiety, Depression, Frustration tolerance decreased, Nervousness, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
34 | 25490250 |
CA |
2 | |
Pulmonary fibrosis, Infusion site reaction, Mite allergy, Mechanical urticaria, Chronic sinusitis, COVID-19, Atelectasis, Pain, Erythema, Pruritus, Fatigue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, METOPROLOL TARTRATE, METOPROLOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MOMETASONE FUROATE, MOMETASONE, GUAIFENESIN, RIVAROXABAN, CYCLOSPORINE, PREGABALIN, LIRAGLUTIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, RIVAROXABAN, PROGESTERONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
35 | 25490266 |
US |
60 | 2 |
Photosensitivity reaction, Sunburn, Erythema, Swelling face, Acne, |
||||
SARILUMAB, |
||||
36 | 25490376 |
JP |
70 | 1 |
Prostatitis, Urinary retention, Dehydration, Renal failure, Urticaria, Erythema, Pruritus, Seborrhoeic dermatitis, |
||||
RIVAROXABAN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, TAMSULOSIN HYDROCHLORIDE, CEFTRIAXONE SODIUM, ENALAPRIL MALEATE, ENALAPRIL, MAGNESIUM OXIDE, |
||||
37 | 25490873 |
CA |
2 | |
Herpes zoster, Nasopharyngitis, Off label use, Rash, Sleep disorder, Urticaria, Drug ineffective, Erythema, Pain, Product use in unapproved indication, Pruritus, |
||||
AMLODIPINE, AMLODIPINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, CLONAZEPAM, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, PREDNISONE, TRANDOLAPRIL, TRANDOLAPRIL TABLETS, TRANDOLAPRIL, TRANDOLAPRIL TABLETS, |
||||
38 | 25500379 |
15 | 1 | |
Swelling, Erythema, Pruritus, Dry skin, Skin exfoliation, |
||||
OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, |
||||
39 | 25484642 |
85 | 1 | |
Hordeolum, Erythema, |
||||
PIRFENIDONE, |
||||
40 | 25486447 |
US |
2 | |
Erythema, Chest pain, Back pain, Musculoskeletal chest pain, Papule, |
||||
NILOTINIB, AMLODIPINE, DICLOFENAC SODIUM, HYDROCHLOROTHIAZIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOSARTAN, SIMVASTATIN, |
||||
41 | 25486495 |
US |
66 | 2 |
Nausea, Vomiting, Dizziness, Abdominal pain upper, Diarrhoea, Decreased appetite, Dehydration, Palpitations, Erythema, Erythema, Hyperhidrosis, Dyspnoea, Sepsis, |
||||
SEMAGLUTIDE, |
||||
42 | 25486756 |
US |
18 | 2 |
Erythema, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
43 | 25487010 |
US |
55 | 1 |
Acne, Erythema, Pruritus, Rash, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
44 | 25487161 |
PT |
80 | 2 |
Vomiting, Dizziness, Hyperhidrosis, Fatigue, Paraesthesia, Tremor, Erythema, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ERYTHROPOIETIN, IRBESARTAN, IRON, |
||||
45 | 25487295 |
CA |
||
Crohn^s disease, Erythema, Skin exfoliation, Intentional product use issue, |
||||
USTEKINUMAB, |
||||
46 | 25487457 |
GB |
51 | 2 |
Erythema, |
||||
FAMOTIDINE, |
||||
47 | 25487528 |
US |
6 | 1 |
Pruritus, Erythema, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
48 | 25487911 |
GB |
||
Joint swelling, Erythema, Dry skin, Oedema blister, |
||||
FULVESTRANT, PALBOCICLIB, |
||||
49 | 25488109 |
BE |
42 | 2 |
Flushing, Erythema, Pruritus, Tachycardia, Dyspnoea, |
||||
OFATUMUMAB, |
||||
50 | 25488170 |
BR |
64 | 2 |
Haematochezia, Anal fissure, Rectal abscess, Anal fistula, Skin discolouration, Pain in extremity, Blister, Skin exfoliation, Erythema, Aphthous ulcer, Oral pain, Decreased appetite, Weight decreased, Diarrhoea, Incorrect dose administered, |
||||
REGORAFENIB, REGORAFENIB, REGORAFENIB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SIMVASTATIN, ERGOCALCIFEROL, PSYLLIUM HUSK, DIGITALIS, |
||||
51 | 25488465 |
US |
45 | 2 |
Erythema, Pruritus, Skin burning sensation, |
||||
LEVONORGESTREL, DUPILUMAB, |
||||
52 | 25488807 |
US |
80 | 1 |
Erythema, Increased tendency to bruise, Libido decreased, Sleep disorder, Depression, Peripheral swelling, Skin atrophy, Fatigue, Asthenia, |
||||
ETANERCEPT, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, CELECOXIB, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FINASTERIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, LOSARTAN POTASSIUM, LOSARTAN, |
||||
53 | 25488876 |
GB |
2 | |
Hypoxia, Erythema, Flushing, Back pain, Nausea, |
||||
PACLITAXEL, |
||||
54 | 25488884 |
US |
||
Palpitations, Erythema, Product preparation error, Off label use, |
||||
55 | 25489120 |
US |
76 | 2 |
Dry skin, Erythema, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
56 | 25489254 |
US |
17 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
57 | 25489310 |
US |
51 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
58 | 25489347 |
US |
4 | 2 |
Erythema, Eyelid skin dryness, Skin exfoliation, |
||||
DUPILUMAB, |
||||
59 | 25489458 |
US |
8 | 1 |
Pruritus, Rebound effect, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
60 | 25489689 |
US |
85 | 2 |
Type 2 diabetes mellitus, Peripheral swelling, Pain in extremity, Erythema, Ageusia, Anosmia, Impaired healing, Scratch, Scab, Dry skin, Product dose omission issue, |
||||
LORLATINIB, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, CALCIUM CARBONATE, ANTACID, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, DENOSUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, EZETIMIBE, FUROSEMIDE, GABAPENTIN, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, STANDARDIZED SENNA CONCENTRATE, TORSEMIDE, ERGOCALCIFEROL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
61 | 25489737 |
US |
||
Erythema, Skin irritation, Dry skin, Skin exfoliation, Pruritus, Skin burning sensation, Dermatitis, Drug ineffective, Inappropriate schedule of product administration, Underdose, |
||||
ADAPALENE, ADAPALENE, |
||||
62 | 25489923 |
US |
40 | 1 |
Skin reaction, Skin irritation, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
63 | 25489928 |
US |
48 | 1 |
Erythema, Lip swelling, Urticaria, Pruritus, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, |
||||
64 | 25490438 |
US |
34 | 2 |
Eczema, Pruritus, Erythema, Dermatitis, |
||||
DUPILUMAB, RUXOLITINIB, |
||||
65 | 25490619 |
US |
54 | 2 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
66 | 25490631 |
SG |
58 | 2 |
Internal haemorrhage, Erythema, Peripheral swelling, |
||||
ADO-TRASTUZUMAB EMTANSINE, |
||||
67 | 25490722 |
SE |
58 | 2 |
Nausea, Pyrexia, Blister, Rash, Erythema, Influenza like illness, Pancytopenia, Face oedema, Pruritus, Rash, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), LEVETIRACETAM, LEVETIRACETAM, PHENYTOIN, PHENYTOIN, LACTULOSE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN POTASSIUM, |
||||
68 | 25493557 |
65 | 1 | |
Rash, Urticaria, Skin reaction, Erythema, Skin burning sensation, |
||||
LENALIDOMIDE, |
||||
69 | 25493927 |
55 | 1 | |
Erythema, Peripheral swelling, Cellulitis, |
||||
RIOCIGUAT, MACITENTAN, SELEXIPAG, RISPERIDONE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DULOXETINE HYDROCHLORIDE, DULOXETINE, LITHIUM CARBONATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, WARFARIN, TORSEMIDE, SPIRONOLACTONE, SOTATERCEPT-CSRK, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, |
||||
70 | 25499479 |
79 | 2 | |
Swelling face, Eye swelling, Erythema, Inflammation, Pruritus, Dizziness, |
||||
OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS CAPSULES, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
71 | 25481250 |
CO |
28 | 2 |
Pain, Pruritus, Skin burning sensation, Erythema, |
||||
PANITUMUMAB, |
||||
72 | 25481276 |
CA |
2 | |
Drug hypersensitivity, Erythema, Lower respiratory tract infection, Pain, Peripheral swelling, Rash, |
||||
METHOTREXATE SODIUM, ETANERCEPT, |
||||
73 | 25481710 |
US |
9 | 1 |
Erythema, Contusion, Sensitive skin, |
||||
GIVINOSTAT, AMOXICILLIN, MELATONIN, DEFLAZACORT, ALBUTEROL SULFATE, ALBUTEROL, IRON, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, SERTRALINE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
74 | 25481853 |
CN |
76 | |
Erythema, Pruritus, Pain, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
75 | 25482172 |
US |
69 | 2 |
Erythema, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
76 | 25482442 |
US |
2 | |
Depressed mood, Abdominal discomfort, Dizziness, Erythema, Asthenia, Pruritus, |
||||
ADALIMUMAB-ADAZ, |
||||
77 | 25482511 |
TR |
66 | 2 |
Pain, Erythema, Vision blurred, Anterior chamber cell, Vitreous disorder, Off label use, |
||||
BEVACIZUMAB, |
||||
78 | 25483325 |
US |
2 | |
Thrombocytopenia, Epistaxis, Rash, Erythema, Polycythaemia, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, |
||||
79 | 25483536 |
CA |
67 | 2 |
Condition aggravated, Arthritis, Hypertension, Therapeutic product effect decreased, Inflammation, Blood parathyroid hormone decreased, Panniculitis, Headache, Synovitis, Dermatitis, Alopecia, Erythema, Nausea, Hypercalcaemia, Rheumatoid arthritis, Hepatic enzyme increased, Pain, Joint swelling, Neoplasm skin, Peripheral swelling, Prescribed underdose, Fatigue, Pruritus, Rheumatoid nodule, Red blood cell sedimentation rate increased, Rheumatoid factor positive, Arthropathy, Musculoskeletal stiffness, Ulcer, Off label use, Hypersensitivity, Infusion related reaction, Aspartate aminotransferase increased, Pulmonary fibrosis, Skin ulcer, Loss of personal independence in daily activities, Pneumonia, Abdominal pain, Drug eruption, Granuloma skin, Drug hypersensitivity, C-reactive protein increased, Breath sounds abnormal, Drug intolerance, Alanine aminotransferase increased, Insomnia, Drug tolerance, Arthralgia, Gastrointestinal disorder, Rash pruritic, Basal cell carcinoma, C-reactive protein abnormal, Skin necrosis, Hepatitis, Rash, Vomiting, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, AZATHIOPRINE, INFLIXIMAB, CELECOXIB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROXYCHLOROQUINE, PREDNISONE, CERTOLIZUMAB PEGOL, ADALIMUMAB, INFLIXIMAB, BUDESONIDE, ATENOLOL, ALENDRONATE SODIUM, CYCLOSPORINE, PROPRANOLOL HYDROCHLORIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RITUXIMAB, RITUXIMAB, AMLODIPINE BESYLATE, SULFASALAZINE, PREGABALIN, GOLD, CELECOXIB, RAMIPRIL, MAGNESIUM OXIDE, ERGOCALCIFEROL, ABATACEPT, NAPROXEN, NAPROXEN SODIUM, BENDAMUSTINE HYDROCHLORIDE, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CYANOCOBALAMIN, SERTRALINE HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, TOFACITINIB, LEFLUNOMIDE, ELBASVIR AND GRAZOPREVIR, LENALIDOMIDE, |
||||
80 | 25483738 |
US |
61 | 2 |
Erythema, Pruritus, Dysphagia, Oropharyngeal discomfort, Dysphonia, Cough, Off label use, |
||||
GADOTERATE MEGLUMINE, |
||||
81 | 25483755 |
US |
2 | |
Erythema, Product supply issue, |
||||
LECANEMAB, |
||||
82 | 25484126 |
US |
45 | 2 |
Skin lesion, Erythema, Pruritus, Skin swelling, Dermatitis acneiform, Oral herpes, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
83 | 25484140 |
US |
18 | 2 |
Rash, Erythema, Skin discolouration, Rebound effect, Sleep disorder due to a general medical condition, Rebound effect, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
84 | 25484185 |
US |
19 | 1 |
Rebound eczema, Erythema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
85 | 25484201 |
US |
65 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
86 | 25484214 |
US |
57 | 2 |
Hot flush, Skin mass, Skin odour abnormal, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
87 | 25484235 |
US |
31 | 2 |
Erythema, Urticaria, Rash, Arthralgia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
88 | 25484267 |
US |
71 | 1 |
Pain, Erythema, Rash erythematous, Scratch, Product use in unapproved indication, |
||||
DUPILUMAB, FISH OIL, |
||||
89 | 25484473 |
1 | ||
Injection site reaction, Skin reaction, Erythema, Pain, Rash papular, Pruritus, |
||||
90 | 25485168 |
FR |
44 | 1 |
Erythema, Eosinophilia, |
||||
LEVETIRACETAM, |
||||
91 | 25485321 |
US |
2 | |
Erythema, |
||||
PERFLUOROHEXYLOCTANE, LIFITEGRAST, |
||||
92 | 25485357 |
US |
35 | 1 |
Rebound eczema, Erythema, Dry skin, Skin fissures, Pruritus, Injection site pain, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
93 | 25485370 |
US |
24 | 1 |
Erythema, Eye pruritus, Dry eye, Eye irritation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
94 | 25485682 |
US |
||
Skin exfoliation, Myalgia, Pain of skin, Muscle spasms, Skin atrophy, Erythema, |
||||
NEMOLIZUMAB-ILTO, SERTRALINE, |
||||
95 | 25485717 |
US |
||
Dermatitis atopic, Erythema, Skin hypertrophy, |
||||
NEMOLIZUMAB-ILTO, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
96 | 25485737 |
US |
||
Contusion, Sensitive skin, Erythema, |
||||
NEMOLIZUMAB-ILTO, |
||||
97 | 25485831 |
US |
||
Rash, Erythema, Dry skin, Pruritus, Arthralgia, Headache, Myalgia, |
||||
NEMOLIZUMAB-ILTO, |
||||
98 | 25485916 |
US |
||
Eczema, Pain in extremity, Chills, Malaise, Skin exfoliation, Erythema, Skin discolouration, |
||||
NEMOLIZUMAB-ILTO, |
||||
99 | 25485948 |
US |
||
Contusion, Osteitis, Dermatitis atopic, Blister, Erythema, Pruritus, Skin exfoliation, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
100 | 25485961 |
US |
||
Erythema, Rash macular, |
||||
NEMOLIZUMAB-ILTO, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29